Related Experiment Video
Updated: Jul 16, 2026
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Marfan's syndrome and the heart.
Alan Graham Stuart1, Andrew Williams
1Congenital Heart Centre, Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol, UK. agstuart@blueyonder.co.uk
Archives of Disease in Childhood
|March 23, 2007
Summary
Advances in treating pediatric Marfan syndrome cardiovascular disease include early diagnosis and beta-blocker therapy. Future treatments targeting TGFbeta signaling show promise for aortic root dilatation.
Area of Science:
- Pediatric Cardiology
- Genetics
- Cardiovascular Medicine
Background:
- Marfan syndrome is a genetic disorder affecting connective tissue, leading to cardiovascular complications, primarily aortic root dilatation.
- Cardiovascular issues are the leading cause of morbidity and mortality in children with Marfan syndrome.
- Management requires a multidisciplinary approach to address complex health needs.
Purpose of the Study:
- To review recent advances in the diagnosis and management of cardiovascular disease in pediatric Marfan syndrome.
- To highlight the importance of early detection and ongoing monitoring.
- To discuss current and emerging therapeutic strategies.
Main Methods:
- Review of current literature on Marfan syndrome and cardiovascular disease in children.
- Analysis of diagnostic tools, including echocardiography.
- Evaluation of medical and potential future treatments.
Main Results:
- Early diagnosis and regular echocardiographic follow-up are crucial for effective management.
- Beta-blocker therapy is likely beneficial for children with aortic root dilatation.
- Ongoing research into TGFbeta signaling pathways may offer novel therapeutic targets.
Conclusions:
- A multidisciplinary approach is essential for managing cardiovascular complications in pediatric Marfan syndrome.
- Current management focuses on early detection, monitoring, and medical therapy.
- Emerging research holds potential for future treatment advancements, pending clinical trial outcomes.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...